| Dr Mona Shah Professional Corporation | |
|
1600 S Gaffey St San Pedro CA 90731-4628 | |
| (310) 548-0201 | |
| (310) 547-3340 |
| Full Name | Dr Mona Shah Professional Corporation |
|---|---|
| Speciality | Internal Medicine |
| Location | 1600 S Gaffey St, San Pedro, California |
| Authorized Official Name and Position | Mona Shah (OWNER) |
| Authorized Official Contact | 3105480201 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mona Shah Professional Corporation 1600 S Gaffey St San Pedro CA 90731-4628 Ph: (310) 548-0201 | Dr Mona Shah Professional Corporation 1600 S Gaffey St San Pedro CA 90731-4628 Ph: (310) 548-0201 |
| NPI Number | 1053643171 |
|---|---|
| Provider Enumeration Date | 02/01/2010 |
| Last Update Date | 09/25/2020 |
| Medicare PECOS PAC ID | 2062548084 |
|---|---|
| Medicare Enrollment ID | O20100405000187 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053643171 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A56119 (California) | Primary |
| Provider Name | Valerie Grant |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1922041102 PECOS PAC ID: 8921093303 Enrollment ID: I20040416000339 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Sharon F Genato |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1902906555 PECOS PAC ID: 1355330101 Enrollment ID: I20040507000998 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Mona S Shah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609087543 PECOS PAC ID: 3678531902 Enrollment ID: I20050103000603 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Jillian Sally Gray |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639296957 PECOS PAC ID: 7113931445 Enrollment ID: I20060125001027 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Lilia Prado-gober |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1326107954 PECOS PAC ID: 0547322976 Enrollment ID: I20081219000039 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Mirko A Giaconi |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1609850700 PECOS PAC ID: 1456496314 Enrollment ID: I20100303000204 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Neda Khadem |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1184951345 PECOS PAC ID: 3274660592 Enrollment ID: I20100419000463 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Stephen D Taus |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508896259 PECOS PAC ID: 8325237449 Enrollment ID: I20110105000710 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Curtis Foster |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1477710028 PECOS PAC ID: 2365761764 Enrollment ID: I20150506002917 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Anastasia Buerger |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1437699774 PECOS PAC ID: 6507291291 Enrollment ID: I20200128000788 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Robert M Thayer |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396199378 PECOS PAC ID: 5395172134 Enrollment ID: I20200217004154 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Carolyn Joann Vargas |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669654885 PECOS PAC ID: 7911231543 Enrollment ID: I20200414003378 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
| Provider Name | Paul Sliskovich |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1245892934 PECOS PAC ID: 1456680446 Enrollment ID: I20220715000318 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation: Journal of the American Heart Association.
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium H. pylori. Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.
CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.
› Verified 8 days ago
Ramin Alizadeh Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1534 W 25th St, San Pedro, CA 90732 Phone: 310-547-3034 Fax: 310-548-5242 | |
San Miguel Urgent Care San Pedro Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 525 W 7th St, San Pedro, CA 90731 Phone: 424-264-5630 | |
Mark Perez Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1350 W 6th St, 2nd Floor #7, San Pedro, CA 90732 Phone: 310-832-1126 Fax: 310-831-3000 | |
Jeremy Anuntiyo Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1360 W 6th St Ste 310, San Pedro, CA 90732 Phone: 562-529-7772 Fax: 562-529-5449 | |
Multicare Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 505 S Pacific Ave, Suite #201, San Pedro, CA 90731 Phone: 424-570-6960 Fax: 424-570-6952 | |
Total Body Advanced Medicine, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 789 W 9th St, San Pedro, CA 90731 Phone: 310-519-1557 Fax: 310-519-0330 |